Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Build coalitions with organizations and leaders in the psychedelic advocacy community.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JUNE 18, 2021

Minimum of 5 years of relevant industry experience in biotechnology or pharmaceutical companies demonstrating strong data mining and filtering skills. Adept at searching online databases (e.g.

Business 104

Business Research and Development Advocacy Data 104

Veriheal

JUNE 20, 2022

” The LPP’s mission is: “Through intervention, advocacy, and awareness campaigns the Last Prisoner Project works to redress the past and continuing harms of these unjust laws and policies.” The FDA has also approved a few cannabis-based pharmaceutical drugs. According to the U.S.

Chronic Pain 97

Chronic Pain Advocacy Pharmaceutical Legalization 97

Cannabis Law Report

OCTOBER 14, 2021

formerly the Canadian Association of Retired Persons), Canada’s largest advocacy association for Canadians As We Age. patients must register at Opticann.ca ’s advocacy. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce an exclusive partnership between its subsidiary Opticann and C.A.R.P.

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52

NORML

NOVEMBER 8, 2019

Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.

Access 209

Access Marijuana Treatment Legislation 209

Cannabis Law Report

JUNE 26, 2019

First and foremost, I’ll highlight the patient perspective, patients like myself who are legally registered State of Florida Medical Marijuana active ID cardholders. I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Program between St. Bonaventure University and George Washington University School of Medicine. . School: University of Maryland.

Research and Development 117

Research and Development Education Agriculture Patients 117

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. NH resident?

Legislation 195

Legislation Decriminalization Hemp Patients 195

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

JANUARY 5, 2022

Registered 23,000 patients for our Compassionate Pricing Program through Spectrum Therapeutics. Conducted our first-ever baseline assessment of our Scope 1 and Scope 2 energy use and GHG emissions. Invested over $1 million in supporting record-clearing, wrap-around and ancillary services for people impacted by the war on drugs. THE REPORT.

Pharmaceutical 52

Pharmaceutical Agriculture Programs Safety 52

NORML

FEBRUARY 1, 2019

Legislation is pending, House Bill 6849, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit medical cannabis patients to grow up to six cannabis plants. CT resident? Click here to email your lawmakers in support of home cultivation rights. IA resident?

Legislation 165

Legislation Decriminalization Access Patients 165

SpeedWeed

AUGUST 16, 2021

After receiving her PhD from the University of California at Berkeley, she was named Director of Research and Patient Services at Berkeley Patients Group, one of the oldest dispensaries in the country. . Gardening, Understanding & Advocacy . Amanda Reiman has worn many hats in the cannabis space. and abroad. . Shutterstock.

Chronic Pain 52

Chronic Pain Dispensary Supply Chain THC 52

Cannabis Law Report

DECEMBER 22, 2019

With a clear passion for cannabis advocacy, Aurora is grateful for his contributions to the company’s growth and role as a global medical cannabis leader. Australia has seen dramatic growth in the medical cannabis space over the last 18 months from less than 500 patients in June of 2018 to over 24,000 as of November 2019.

Research and Development 59

Research and Development Wellness and Beauty Pharmaceutical Events 59

Puff Puff Post

FEBRUARY 4, 2019

Tanski and other experts will meet this Friday at the Food and Drug Administration to discuss the potential role for pharmaceutical therapies and non-prescription medications such as nicotine gums and patches. “They don’t perceive the harm, and we can’t show them what it’s going to be.”. About two-thirds of U.S.

Vaping 101

Vaping Therapy Programs Advocacy 101

Cannabis Law Report

JULY 18, 2019

All of our state MMTC FL licensed clinics and dispensaries incorporate the lofty goals of both patient and product availability ( access ) and affordability ( cost ). . As with any other medical treatment, providers, patients and regulators need the necessary information to evaluate its benefits and risks.”. AUTHOR: Heather Allman.

Marijuana 40

Marijuana Dispensary Research and Development Patients 40

CannaTech

NOVEMBER 10, 2019

I spoke to Namibian cannabis activist Angela Prusa about her country’s efforts to suppress cannabis advocacy. Another important aspect of legalization is that people use cannabis for their health, even where pharmaceuticals have fallen short. Angela was born in Windhoek, Namibia and grew up in the Kuiseb and in Omaruru, Namibia.

History 40

History Research and Development Cannabis Education 40

CannaTech

NOVEMBER 19, 2019

I spoke to activist Angela Prusa about cannabis in Namibia and recent government efforts to suppress cannabis advocacy. Another important aspect of legalization is that people use cannabis for their health, even where pharmaceuticals have fallen short.

History 80

History Research and Development Cannabis Education 80

CannaTech

NOVEMBER 19, 2019

I spoke to activist Angela Prusa about cannabis in Namibia and recent government efforts to suppress cannabis advocacy. Another important aspect of legalization is that people use cannabis for their health, even where pharmaceuticals have fallen short.

History 76

History Research and Development Cannabis Education 76

Cannabis Law Report

APRIL 22, 2019

Under current federal and state legislation, patients suffering from severe health conditions can legally access prescription-based medicinal cannabis in Australia. “Until then the only legal hope for millions of Australian chronic pain patients is the ‘Thailand twist’ ” Source: [link].

Chronic Pain 10

Chronic Pain Medicine Conditions Access 10

SpeedWeed

JULY 19, 2021

High Times was contacted by cannabis warrior and concerned advocate Amy Smoot, who gave testimony at this meeting on behalf of three different families who had young children who couldn’t be treated with traditional pharmaceutical medications. I see cannabis being used as an exit from dangerous and harmful pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Patients Legislation Medicine 52

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients. Marijuana policy should be evidence based.

Policy 160

Policy Patients Education Legislation 160

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. There were somewhat of a, I want to say grey, but it wasn’t the pharma routes for patients in the US who wanted to get certain products, you know?

Supply Chain 120

Supply Chain Patients Access Hemp 120

SMPL

MAY 26, 2020

Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Ringo’s high-CBD plants and seeds, spreading the gospel at pot shops across the West.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MARCH 19, 2020

In countries or states where medical marijuana is legal, doctors can prescribe it to alleviate nerve pain or glaucoma, or at times to help with nausea caused due to chemotherapy for cancer patients as well as treatment of HIV patients. Investment in cannabis/ marijuana is not new. Faraz Alam Sagar.

Legalization 59

Legalization Banking Research and Development Nerve Pain 59

Cannabis Law Report

SEPTEMBER 10, 2019

Still, Maguire reckons patient advocacy, combined with a growing chorus of scientific experts, will be enough to shift the regulatory environment towards acceptance and adoption. With adoption, Europe is rather different to Asia or the US Swift growth here is by no means guaranteed, considering regulations being what they are.

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

Cannabis Law Report

DECEMBER 2, 2021

InterCure will leverage its licensed international supply chain to serve the growing communities of medical cannabis patients in Europe. Cookies also actively works to enrich communities disproportionately impacted by the War on Drugs through advocacy and social equity initiatives.

Supply Chain 52

Supply Chain Seed-To-Sale Media Events 52

Cannabis Law Report

FEBRUARY 2, 2020

On the topic of sustainability, Florida also currently lacks a dedicated patient or clinic “cannabis collection” station for used cannabis products; an integrated program for safe disposal here in Florida must be addressed, by the Medical Marijuana Advisory Committee or other dedicated state body. .

Hemp 69

Hemp Research and Development Packaging Cultivation 69

The Cannigma

DECEMBER 22, 2021

It doesn’t mean, necessarily, that the market should go to full legalization within a year or two, because it won’t happen so fast, but you can have more patients with other medical indications that were not given cannabis before. Obviously, that means that there are more patients and there are more products to sell.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

NORML

JANUARY 2, 2019

Thus every pound of cannabis which is donated free of charge to legal patients is liable for nearly $1000 in state taxes.”. Grower Advocacy Council and the Mass. Patient Advocacy Alliance to Host Second Annual Harvest Cup. “We Read more from City Watch ! MassCann NORML Joins Mass. Read more from The Charlotte Observer !

Advocacy 126

Advocacy Decriminalization Legislation Cultivation 126

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Nikki’s story is deeply inspirational, and we are honored to have had her on the show.

Patients 83

Patients Compliance Compliance Cannabis 83

The Cannigma

DECEMBER 8, 2021

To hear more of JM’s thoughts on the importance of small victories, how to build momentum, and patient rights, tune in today! And I think it’s an interesting question that I get it a lot and I’ve heard it asked of other patients as well, and I think it’s kind of a question that we all take for granted is like the one to ask.

Access 81

Access Policy Patients Cannabis 81

NORML

FEBRUARY 8, 2019

Legislation is pending, Proposed Bill 350, to limit patients who use medical cannabis in compliance with state law from seeking civil actions if they are discriminated against by their employer. Click here to email your lawmakers in opposition to restricting patients’ employment rights. NORML opposes this legislation.

Legislation 176

Legislation Decriminalization Patients Access 176

NORML

JANUARY 25, 2019

And a North Dakota bill to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes was defeated in a Senate committee this week. Democratic State Senator Bill Montford re-introduced Senate Bill 384, which would allow qualified patients to use medical cannabis while in school. FL resident?

Legislation 152

Legislation Patients Oil Hemp 152

Cannabis Law Report

JUNE 4, 2021

Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers. Healing Advocacy Fund. Jonathan is the CEO and founder of Gilgamesh Pharmaceuticals. Brian Muraresku. Sam Chapman.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

NORML

MARCH 14, 2019

A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction CAPS (Clinician Administered Post-traumatic Scale) symptom scores following cannabis therapy. Send a message now to your lawmakers.

Access 215

Access Chronic Pain Treatment Conditions 215

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45